`Tel: 571-272-7822
`
`
`
`
` Paper 72
`Entered: June 27, 2022
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`MYLAN PHARMACEUTICALS INC., CELLTRION, INC., and APOTEX,
`INC.,
`Petitioner,
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner.
`
`
`
`
`
`
` IPR2021-00880 (Patent 9,669,069 B2)1
` IPR2021-00881 (Patent 9,254,338 B2)2
`
`
`Before ERICA A. FRANKLIN, JOHN G. NEW, and
`SUSAN L. C. MITCHELL, Administrative Patent Judges.
`
`PER CURIAM.
`
`
`ORDER3
`Granting Petitioner’s Unopposed Motions for Admission pro hac vice of
`Robert Cerwinski, Brigid Morris, and Aviv Zalcenstein
`37 C.F.R. § 42.10
`
`
`1 IPR2022-00257 and IPR2022-00301 have been joined with this
`proceeding.
`2 IPR2022-00258 and IPR2022-00298 have been joined with this
`proceeding.
`3 The combined caption is for administrative convenience only and does not
`indicate that IPR2021-00880 and IPR2021-00881 have been joined. The
`parties are not authorized to use this caption without express permission of
`the Board.
`
`
`
`IPR2021-00880 (Patent 9,669,069 B2)
`IPR2021-00881 (Patent 9,254,338 B2)
`
`
`
`Celltrion Inc. (“Petitioner”) filed motions for admission pro hac vice
`
`of Robert Cerwinski, Brigid Morris, and Aviv Zalcenstein in the proceedings
`
`listed above. Papers 62, 63, and 65 (collectively, the “Motions”).4
`
`Petitioner also filed supporting declarations from Mr. Cerwinski, Ms.
`
`Morris, and Mr. Zalcenstein. Ex. 1132–1134. Petitioner states that the
`
`Motions are unopposed. See Paper 62, 1.
`
`Pursuant to 37 C.F.R. § 42.10(c), the Board may recognize counsel
`
`pro hac vice during a proceeding upon a showing of good cause, subject to
`
`the condition that lead counsel be a registered practitioner. In authorizing
`
`motions for admission pro hac vice, the Board requires a statement of facts
`
`showing there is good cause for the Board to recognize counsel pro hac vice,
`
`and an affidavit or declaration of the individual seeking to appear in these
`
`proceedings. See Paper 3, 2 (citing Unified Patents, Inc. v. Parallel Iron,
`
`LLC, IPR2013-00639 (PTAB Oct. 15, 2013) (Paper 7) (representative
`
`“Order – Authorizing Motion for Pro Hac Vice Admission”)).
`
`Upon review of the motions and declarations submitted, we determine
`
`that the requirements of 37 C.F.R. § 42.10 have been satisfied, and that there
`
`is good cause to admit Mr. Cerwinski, Ms. Morris, and Mr. Zalcenstein pro
`
`hac vice for the above-noted proceedings.
`
`
`
`
`4 All citations are to IPR2021-00880 and the ’069 patent, with the
`understanding that IPR2021-00881 includes papers having substantially
`the same substantive content, unless otherwise noted.
`
`
`
`2
`
`
`
`IPR2021-00880 (Patent 9,669,069 B2)
`IPR2021-00881 (Patent 9,254,338 B2)
`
`
`
`It is, therefore,
`
`ORDERED that the Motions for Admission pro hac vice of Robert
`
`Cerwinski are granted and Mr. Cerwinski is authorized to represent
`
`Petitioner as back-up counsel in the above-listed proceedings;
`
`FURTHER ORDERED that the Motions for Admission pro hac vice
`
`of Brigid Morris are granted and Ms. Morris is authorized to represent
`
`Petitioner as back-up counsel in the above-listed proceedings;
`
`FURTHER ORDERED that the Motions Admission pro hac vice of
`
`Aviv Zalcenstein are granted and Mr. Zalcenstein is authorized to represent
`
`Petitioner as back-up counsel in the above-listed proceedings;
`
`FURTHER ORDERED that a registered practitioner will continue to
`
`represent Petitioner as lead counsel in the above-listed proceedings;
`
`FURTHER ORDERED that Mr. Cerwinski, Ms. Morris, and Mr.
`
`Zalcenstein shall comply with the Office Patent Trial Practice Guide, as
`
`updated by the Patent Trial and Appeal Board Consolidated Trial Practice
`
`Guide (84 Fed. Reg. 64,280 (Nov. 21, 2019)) and the Board’s Rules of
`
`Practice for Trials, as set forth in Part 42 of Title 37, Code of Federal
`
`Regulations; and
`
`FURTHER ORDERED that that Mr. Cerwinski, Ms. Morris, and Mr.
`
`Zalcenstein are subject to the USPTO’s Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§ 11.101 et seq. and to the USPTO’s disciplinary
`
`jurisdiction under 37 C.F.R. § 11.19(a).
`
`
`
`
`
`3
`
`
`
`IPR2021-00880 (Patent 9,669,069 B2)
`IPR2021-00881 (Patent 9,254,338 B2)
`
`
`PETITIONER:
`
`Paul Molino
`William Rakoczy
`Neil McLaughlin
`Heinz Salmen
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`paul@rmmslegal.com
`wrakoczy@rmmslegal.com
`nmclaughlin@rmmslegal.com
`hsalmen@rmmslegal.com
`
`Teresa Rea
`Deborah Yellin
`Shannon Lentz
`CROWELL & MORING LLP
`trea@crowell.com
`dyellin@crowell.com
`slentz@crowell.com
`
`Lora Green
`Yahn-Lin Chu
`WILSON SONSINI GOODRICH & ROSATI
`lgreen@wsgr.com
`ychu@wsgr.com
`
`PATENT OWNER:
`
`Deborah Fishman
`Amanda Antons
`Alice Sin Yu Ho
`ARNOLD & PORTER KAYE SCHOLER LLP
`deborah.fishman@kayescholer.com
`amanda.antons@arnoldporter.com
`alice.ho@arnoldporter.com
`
`
`
`4
`
`